Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial.

Respir Res · 2019 · PMC6892023 · PMID 31796013

Europe PMC DOI

hedged sentences

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendP = .070so close (0.05 < p ≤ 0.1)

Intervention had no effect on time to first exacerbation (HR 0.65, 95% CI 0.21 to 2.07, P = .24), but showed a trend toward a 39% decreased frequency of exacerbations (RR = 0.61, 95% CI 0.35 to 1.03, P = .070) for the adjusted models, respectively.

also in 53,322 other papers

a strong trendno p-value reported

did not reach statistical significanceno p-value reported

Despite a strong trend towards greater timing adherence with dry powder capsules, the difference between the two study groups did not reach statistical significance.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.